On Invalid Date, Dexcom (NASDAQ: DXCM) reported Q1 2024 earnings per share (EPS) of $0.38, up 192.31% year over year. Total Dexcom earnings for the quarter were $146.40 million. In the same quarter last year, Dexcom's earnings per share (EPS) was $0.13.
As of Q2 2024, Dexcom's earnings has grown 117.11% year over year. This is 26 percentage points higher than the US Medical Devices industry earnings growth rate of 91.11%. Dexcom's earnings in the past year totalled $639.30 million.
What was DXCM's revenue last quarter?
On Invalid Date, Dexcom (NASDAQ: DXCM) reported Q1 2024 revenue of $921.00 million up 24.21% year over year. In the same quarter last year, Dexcom's revenue was $741.50 million.
What was DXCM's revenue growth in the past year?
As of Q2 2024, Dexcom's revenue has grown 25.78% year over year. This is 16.31 percentage points higher than the US Medical Devices industry revenue growth rate of 9.47%. Dexcom's revenue in the past year totalled $3.80 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.